Literature DB >> 18023233

Interactions of pathogenic mycobacteria with host macrophages.

Varadharajan Sundaramurthy1, Jean Pieters.   

Abstract

Tuberculosis, caused by the bacterium Mycobacterium tuberculosis, is one of the most deadly infectious diseases across the globe. The success of M. tuberculosis is related to its capacity to survive and replicate in macrophages, cells of the host innate immune system that are designed to detect and eliminate pathogens [1,2]. In this review, we will focus on the mechanisms used by the innate system of the host to detect and eliminate mycobacteria and the strategies used by M. tuberculosis to overcome host responses to establish a successful infection.

Entities:  

Mesh:

Year:  2007        PMID: 18023233     DOI: 10.1016/j.micinf.2007.09.007

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  17 in total

Review 1.  Genomic RNAi screening in Drosophila S2 cells: what have we learned about host-pathogen interactions?

Authors:  Sara Cherry
Journal:  Curr Opin Microbiol       Date:  2008-06-06       Impact factor: 7.934

Review 2.  Insights into early mycobacterial pathogenesis from the zebrafish.

Authors:  Robin Lesley; Lalita Ramakrishnan
Journal:  Curr Opin Microbiol       Date:  2008-06-19       Impact factor: 7.934

3.  Effect of Ipr1 on expression levels of immune genes related to macrophage anti-infection of mycobacterium tuberculosis.

Authors:  Na Li; Pengfei Liu; Lianwen Wang; Jingbo Liu; Xiao Yuan; Wei Meng; Yan Dong; Boqing Li
Journal:  Int J Clin Exp Med       Date:  2015-03-15

4.  Histone methyltransferase SUV39H1 participates in host defense by methylating mycobacterial histone-like protein HupB.

Authors:  Imtiyaz Yaseen; Mitali Choudhury; Manjula Sritharan; Sanjeev Khosla
Journal:  EMBO J       Date:  2017-11-23       Impact factor: 11.598

5.  Natural killer cell activation distinguishes Mycobacterium tuberculosis-mediated immune reconstitution syndrome from chronic HIV and HIV/MTB coinfection.

Authors:  Francesca Conradie; Andrea S Foulkes; Prudence Ive; Xiangfan Yin; Katerina Roussos; Deborah K Glencross; Denise Lawrie; Wendy Stevens; Luis J Montaner; Ian Sanne; Livio Azzoni
Journal:  J Acquir Immune Defic Syndr       Date:  2011-11-01       Impact factor: 3.731

6.  Keratinocyte growth factor administration attenuates murine pulmonary mycobacterium tuberculosis infection through granulocyte-macrophage colony-stimulating factor (GM-CSF)-dependent macrophage activation and phagolysosome fusion.

Authors:  Rajamouli Pasula; Abul K Azad; Jason C Gardner; Larry S Schlesinger; Francis X McCormack
Journal:  J Biol Chem       Date:  2015-01-20       Impact factor: 5.157

7.  A systems biology framework for modeling metabolic enzyme inhibition of Mycobacterium tuberculosis.

Authors:  Xin Fang; Anders Wallqvist; Jaques Reifman
Journal:  BMC Syst Biol       Date:  2009-09-15

Review 8.  Mycobacterial signaling through toll-like receptors.

Authors:  Joyoti Basu; Dong-Min Shin; Eun-Kyeong Jo
Journal:  Front Cell Infect Microbiol       Date:  2012-11-23       Impact factor: 5.293

9.  Modeling innate immune response to early Mycobacterium infection.

Authors:  Rafael V Carvalho; Jetty Kleijn; Annemarie H Meijer; Fons J Verbeek
Journal:  Comput Math Methods Med       Date:  2012-12-09       Impact factor: 2.238

10.  Mucosal and systemic immune responses to Mycobacterium tuberculosis antigen 85A following its co-delivery with CpG, MPLA or LTB to the lungs in mice.

Authors:  Julie Todoroff; Muriel M Lemaire; Catherine Fillee; Fabienne Jurion; Jean-Christophe Renauld; Kris Huygen; Rita Vanbever
Journal:  PLoS One       Date:  2013-05-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.